A Phase 3 Randomized double blined placebo controlled study to evaluate the efficacy and safety of GS-5745 conbimed with mFOLFAX6 as first line treatment in patients with advanced gastric or gastroeso

Administered By

Awarded By

Contributors

Start/End

  • March 9, 2016 - June 30, 2020